EU animal tissue rule enforcement threatens existing products
This article was originally published in Clinica
Executive Summary
There is a risk that a large number of medical device companies will be forced to remove from the EU market on September 30 products that have been manufactured utilising animal tissues. It seems that the deadline for meeting the EU Directive 2003/32/EC, introducing detailed specifications for such products within the context of the Medical Devices Directive, is not going to be tenable for the 200 or so products that will need to comply.
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.